Untitled Document
Untitled Document

CMD's Desk

Orbit Biotech, started in 2006 is one of the premier companies of our group. Since 2009, I have been the CMD of Orbit Biotech and with the sincere efforts of out team and passion to excel the company has multiplied it's product and service offerings manyfold. Though as an organization we strive to offer the best products and services to our customers, but our main focus remains of customer satisfaction. With utter humbleness we would like to mention that we have more than 97% customer satisfaction rate and we continuously strive to increase it.

Our main strength is our stringent and uncompromising quality policy and parameters. We make sure that whatever we offer is nothing less than 'perfect'. Keeping pace with the latest technology we keep on upgrading our systems and our offerings to meet the expectation of the global clients.

 I am very confident that in coming years as well we will continue to serve the biotechnology community and aid in the nation building exercise. My scientific, technical and administrative colleagues and I intend to apply our vission, passion, discipline and conscience to lead Orbit Biotech into a new horizon for biotechnology applications and development. Please feel free to contact us at nitinsharma@orbitbiotech.com for any information that you might need and comments that you might wish to make.

 

Nitin Sharma
Chairman Cum
Managing Director

 

Untitled Document


 

OrbiCon 2012 
National Conference on Recent Advancements in Biotechnology

16th-21st Jan, 2011
For registration and details visit
www.orbicon.asia

Untitled Document
Research & Development
Contract Research Division
Products
News Updates

 

Registrations Closed for Research Projects for duration 4 months, 5 months and 6 months starting January, 2012. 

 

 

 

Registrations for EMPOWER, industrial training program 2012 starts 1st Jan, 2012. For Details Contact Helpline : +91. 7814471105. Limited Seats, Register Now.

 

Registrations for Disseratation Projects Starting March, 2012 open. Limited Seats available. 

Untitled Document